Abstract
Background: Pancreatic cancer is the second leading cause of death in tumor diseases worldwide. The expression of NRP1 and the presence of KRAS and BRAF point mutation lead to the cell survival by simultaneously with the SMAD2 and SMAD4 inactivation. In higher stages, we often find deletion of p53.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
